You are here

SAR3419

Sanofi dumps an ImmunoGen cancer drug as it scales back in oncology

Fierce Biotech

Sat, 04/25/15 - 08:33 am

diffuse large B-cell lymphoma

Immunogen begins mid-stage testing of experimental cancer compound, triggers $3M payment

Yahoo/AP

Thu, 10/20/11 - 12:45 pm

non-Hodgkin's lymphoma

Micromet Unveils Another Fast Route To Market, Marks Pfizer As Lead Competitor

Seeking Alpha

Sun, 10/16/11 - 07:05 pm

acute lymphoblastic leukemia

Seattle Genetics

ImmunoGen, Inc. Announces Presentation of Favorable SAR3419 Interim Clinical Data at ASCO

Yahoo/BusinessWire

Sat, 06/4/11 - 10:03 am

non-Hodgkin's lymphoma